{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:03:12Z","timestamp":1784106192705,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["209718"],"award-info":[{"award-number":["209718"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.eplepsyres.2020.106321","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T22:38:46Z","timestamp":1584052726000},"page":"106321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children"],"prefix":"10.1016","volume":"162","author":[{"given":"Wiparat","family":"Manuyakorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plernpit","family":"Likkasittipan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Wattanapokayakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supharat","family":"Suvichapanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wimala","family":"Inunchot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuanjun","family":"Wichukchinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaiyos","family":"Khongkhatithuml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunliya","family":"Thampratankul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasu","family":"Kamchaisatian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwat","family":"Benjaponpitak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surakameth","family":"Mahasirimongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2020.106321_bib0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/epi.12564","article-title":"Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions","volume":"55","author":"Amstutz","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/clpt.2014.159","article-title":"Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing","volume":"96","author":"Caudle","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/tpj.2016.10","article-title":"Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population","volume":"17","author":"Chang","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0020","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/epi.12217","article-title":"HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese","volume":"54","author":"Cheung","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0025","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Gonzalez-Galarza","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/pgs.09.162","article-title":"Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"11","author":"Hung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.seizure.2019.02.011","article-title":"Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population","volume":"66","author":"Ihtisham","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0040","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0055","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/14740338.2012.705828","article-title":"Anticonvulsant hypersensitivity syndrome: an update","volume":"11","author":"Knowles","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0060","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0065","first-page":"10","article-title":"HLA-B allele distribution in samples from Thailand national health examination survey","volume":"23","author":"Mahasirimongkol","year":"2014","journal-title":"J. Health Sci."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0070","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/epi.13509","article-title":"Association of HLA genotypes with phenobarbital hypersensitivity in children","volume":"57","author":"Manuyakorn","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0075","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0080","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1152\/jn.00279.2011","article-title":"A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam","volume":"106","author":"Meehan","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4168\/aair.2019.11.2.241","article-title":"Severe cutaneous adverse reactions in Korean pediatric patients: a study from the Korea SCAR registry","volume":"11","author":"Oh","year":"2019","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0090","first-page":"478","article-title":"HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity","volume":"5","author":"Puangpetch","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0095","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FPC.0000000000000211","article-title":"Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population","volume":"26","author":"Tassaneeyakul","year":"2016","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0110","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00228-017-2250-2","article-title":"Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions","volume":"73","author":"Yampayon","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0115","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1212\/WNL.0b013e31823b478c","article-title":"Severe cutaneous adverse reactions to antiepileptic drugs in Asians","volume":"77","author":"Yang","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2020.106321_bib0120","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2217\/pgs-2017-0103","article-title":"Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype","volume":"18","author":"Yuliwulandari","year":"2017","journal-title":"Pharmacogenomics"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121119306758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121119306758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:45:19Z","timestamp":1778546719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121119306758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":24,"alternative-id":["S0920121119306758"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106321","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106321"}}